<?xml version="1.0" encoding="UTF-8"?>
<results title="testTrace">
 <result pre="angiotensin-converting enzyme 2 to enter the cell for replication: possible" exact="treatment" post="options related to the reninâ€&quot;angiotensin system http://orcid.org/0000-0003-1332-2466OffringaAnnettep1MontijnRoyp1SinghSandeepp2p3PaulMartinp4http://orcid.org/0000-0002-2836-571XPintoYigal Mp5Pinto-Sietsma*Sara-Joanp2p3[p1], Microbiology"/>
 <result pre="discovery strategies need to be connected, to generate a rational" exact="treatment" post="which can be made available as rapidly as possible."/>
 <result pre="on a solid theoretical understanding of the mechanisms of SARS-CoV-2" exact="infection" post="and host responses, which is coupled to the practical"/>
 <result pre="AT1R antagonists appear to be the ideal candidate for the" exact="treatment" post="of SARS-CoV-2 infection. AT1R antagonists counterbalance the negative consequences"/>
 <result pre="Therefore, we propose to consider using AT1R antagonists in the" exact="treatment" post="of SARS-CoV-2. Coronavirus COVID-19 Reninâ€&quot;angiotensinâ€&quot;aldosterone system Angiotensin receptor blockers"/>
 <result pre="AT1R antagonists seem to be the ideal candidate for the" exact="treatment" post="of SARS-CoV-2 infection. AT1R antagonists counterbalance the negative consequences"/>
 <result pre="Therefore, we propose to consider using AT1R antagonists in the" exact="treatment" post="of SARS-CoV-2. There is much discussion about the role"/>
 <result pre="This suggested that, since all the patients with such a" exact="diagnosis" post="have an indication for treatment with ACEIs or ARBs,"/>
 <result pre="the patients with such a diagnosis have an indication for" exact="treatment" post="with ACEIs or ARBs, the increased risk of these"/>
 <result pre="has proinflammatory, proliferative, and profibrotic functions that are beneficial during" exact="infection" post="and hypoxia but are deleterious if present in a"/>
 <result pre="of coronaviruses are known. and Jia et al. found that" exact="infection" post="of human airway epithelia with SARS coronavirus correlated with"/>
 <result pre="molecular signals that cause the ongoing induction of AngII during" exact="infection" post="with SARS-CoV-2. The function of the RAS in the"/>
 <result pre="of the RAS in the immune response to infections Upon" exact="infection" post="by a previously unencountered virus, the initial immune response"/>
 <result pre="2 Hypothesis of the mechanism of replication of SARS-CoV-2 and" exact="treatment" post="aims to prevent virus replication and initiating activation of"/>
 <result pre="of these organs. It has been shown that the SARS-CoV-2" exact="infection" post="was related to active myocardial injury, myocardial stress, and"/>
 <result pre="higher values of D-dimer and cardiovascular thrombotic events.35 Treating SARS-CoV-2" exact="infection" post="with AT1R antagonists Following the above, SARS-CoV-2 infection by"/>
 <result pre="Treating SARS-CoV-2 infection with AT1R antagonists Following the above, SARS-CoV-2" exact="infection" post="by binding to ACE2 disrupts the normal AngII:ACE2 balance,"/>
 <result pre="of AT1R which appears to be involved in viral uptake," exact="treatment" post="actions should be aimed at preventing or inhibiting this."/>
 <result pre="have virtually no side effects, which make them the ideal" exact="treatment" post="option for SARS-CoV-2 infection. We are not the only"/>
 <result pre="the above hypothesis is correct, it may be expected that" exact="treatment" post="with AT1R inhibitors (ARBs) might limit viral uptake and"/>
 <result pre="and preserve ACE2 functions. On the other hand, the expected" exact="treatment" post="effect will probably depend on the phase of the"/>
 <result pre="depend on the phase of the disease in which the" exact="treatment" post="is initiated. In the early phase, it might be"/>
 <result pre="initiated. In the early phase, it might be expected that" exact="treatment" post="with an AT1R antagonist may completely prevent the excessive"/>
 <result pre="severe disease, as has also been suggested by others.8,9 Other" exact="treatment" post="options Considering our hypothesis on the proinflammatory role of"/>
 <result pre="viral uptake in COVID-19 and the anti-inflammatory effect of ACE2," exact="treatment" post="should ideally prevent viral uptake and replication, while preserving"/>
 <result pre="we may fear that ACE2 is no longer functional after" exact="treatment" post="with chloroquine. As soon as the host is infected,"/>
 <result pre="be postulated that chloroquine appears to be unsuitable for the" exact="treatment" post="of a SARS-CoV-2 infection, whereas it could play a"/>
 <result pre="gycosylation on ACE2. Therefore, research on chloroquine as a preventive" exact="treatment" post="option should be inititated before it can be introduced"/>
 <result pre="which would impair tissues in responding to hypoxia, damage, or" exact="infection" post="by increasing AngII. Antiviral drugs Antiviral drugs may disrupt"/>
 <result pre="the only antiviral drugs that are being used in the" exact="treatment" post="of the infection are the class that prevents viral"/>
 <result pre="drugs that are being used in the treatment of the" exact="infection" post="are the class that prevents viral replication inside the"/>
 <result pre="which secondary infections are the most important. In addition, these" exact="treatment" post="options are rather expensive and, therefore, not attractive for"/>
 <result pre="Research Research on the hypothesis that AT1R antagonists are suitable" exact="treatment" post="options for COVID-19 should consist of randomized controlled clinical"/>
 <result pre="AngII levels induce increased viral uptake, we believe that the" exact="treatment" post="will be most effective when started within 5 days"/>
 <result pre="not to admit a patient to hospital or to give" exact="treatment" post="with mechanical ventilation, there are no other treatment options"/>
 <result pre="to give treatment with mechanical ventilation, there are no other" exact="treatment" post="options for this group of patients. Secondly, clinical data"/>
 <result pre="placebo-controlled randomized Losartan 25 mg o.d. Placebo Non-hospitalized Proven SARS-CoV-2" exact="infection" post="Cough, rhinorrhea, or fever Admission to hospital 580 Yes"/>
 <result pre="placebo-controlled randomized Losartan 50 mg o.d. Placebo Hospitalized Proven SARS-CoV-2" exact="infection" post="Respiratory failure Difference in estimated (PEEP adjusted) P/F ratio"/>
 <result pre="50 mg o.d. day 3 Standard care Hospitalized Proven SARS-CoV-2" exact="infection" post="Respiratory failure Adverse event due to losartan 50 Yes"/>
 <result pre="mg/asprin 150 mg/simvastatin 80 mg o.d. Comparison Hospitalized Suspected SARS-CoV-2" exact="infection" post="Fever, cough, hypoxia 28 day death 10 000 No"/>
 <result pre="randomized comparison Losartan 25 mg o.d. Placebo Hospitalized Proven SARS-CoV-2" exact="infection" post="NCOSS scores 4000 Yes NCT04340557 Sharp HealthCare Multicentre open"/>
 <result pre="randomized Losartan 12.5 mg t.i.d Standard care Hospitalized Proven SARS-CoV-2" exact="infection" post="Requiring oxygen ICU admission for mechanical ventilation 200 Yes"/>
 <result pre="trial, factorial, randomized Losartan 25 mg o.d. Comparison Proven SARS-CoV-2" exact="infection" post="Improvement in FMTVDM measurement with nuclear imaging. 500 Enrolling"/>
 <result pre="randomized Candesartan 4 mg o.d. Standard care Hospitalized Proven SARS-CoV-2" exact="infection" post="Sustained improvement (&amp;gt;48 h) of one point on the"/>
 <result pre="randomized Telmisartan 80 mg t.d. Standard care Hospitalized Proven SARS-CoV-2" exact="infection" post="Need for supplementary oxygen 400 Yes NCT04335786 Radboud University"/>
 <result pre="titrated up to 160 mg o.d. Placebo Hospitalized Proven SARS-CoV-2" exact="infection" post="Admission to the ICU for mechanical ventilation or death"/>
 <result pre="randomized Telmisartan 20 mg o.d. Vitamin complex Non-hospitalized Proven SARS-CoV-2" exact="infection" post="Age â‰¥ 65 years Proportion of participants with an"/>
 <result pre="PerlmanS, McCrayPBJr.ACE2 receptor expression and severe acute respiratory syndrome coronavirus" exact="infection" post="depend on differentiation of human airway epithelia. J Virol2005;79:14614â€&quot;14621.16282461"/>
 <result pre="infected patients. Crit Care2020;24:155.32299479 35TangN, BaiH, ChenX, GongJ, LiD, SunZ.Anticoagulant" exact="treatment" post="is associated with decreased mortality in severe coronavirus disease"/>
 <result pre="KsiazekTG, SeidahNG, NicholST.Chloroquine is a potent inhibitor of SARS coronavirus" exact="infection" post="and spread. Virol J2005;2:69.16115318 42KhanA, BenthinC, ZenoB, AlbertsonTE, BoydJ,"/>
</results>
